Trump Signs Executive Order to Slash Drug Prices, Target PBMs

Trump signs executive order (EO) tying U.S. drug prices to global benchmarks and targeting PBMs. LPL Research discusses the EO and the market response.

Sector Plays for the Bull Case Scenario

LPL Research highlights equity sector opportunities that may perform well if low tariff rates currently in place are maintained.

Weekly Market Performance — May 17, 2024

LPL Research’s Weekly Market Performance for the week of May 13, 2024, highlights new record highs, a decline in consumer inflation data, and tech strength.

Are Tariffs Always Inflationary?

LPL Research discusses the impacts of 2018 tariffs on wholesale and retail inflation.

Weekly Market Performance — January 17, 2025

LPL’s Weekly Market Performance for the week of January 17, 2025, highlights fixed income, currencies, and commodity markets.

Lakeside Talks Sooth U.S.-China Trade Relations

LPL Research explains how trade relations with China created a catalyst for more risk appetite.

Weekly Market Performance — May 9, 2025

LPL’s Weekly Market Performance for the week of May 5, 2025, highlights the first U.S. trade deal, FOMC rate decision, and a rebound in commodities.

Secondaries in 2025: Capitalizing on Structural Momentum

LPL Research examines the growth of the private secondary market.

Secondaries in 2025: Capitalizing on Structural Momentum

LPL Research examines the growth of the private secondary market.

As Seen on TV, Fund Holdings Come & Go; People Are Paramount

LPL Research discusses insights gleaned from meetings with fund managers.